bioRxivImmunologyPreprint
SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies
A. Jeffery-Smith, A. R. Burton, S. Lens, C. Rees-Spear, M. Patel, R. Gopal, L. Muir, F. Aiano, K. J. Doores, J. Y. Chow, S. N. Ladhani, M. Zambon, L. E. McCoy, M. K. Maini
Abstract
Memory B cells (MBC) can provide a recall response able to supplement waning antibodies with an affinity-matured response better able to neutralise variant viruses. We studied a cohort of vulnerable elderly care home residents and younger staff, a high proportion of whom had lost neutralising antibodies (nAb), to investigate their reserve immunity from SARS-CoV-2-specific MBC. Class-switched spike and RBD-tetramer-binding MBC with a classical phenotype persisted five months post-mild/asymptomatic SARS-CoV-2 infection, irrespective of age. Spike/RBD-specific MBC remained detectable in the majority who had lost nAb, although at lower frequencies and with a reduced IgG/IgA isotype ratio. Functional spike/S1/RBD-specific recall was also detectable by ELISpot in some who had lost nAb, but was significantly impaired in the elderly, particularly to RBD. Our findings demonstrate persistence of SARS-CoV-2-specific MBC beyond loss of nAb, but highlight the need for careful monitoring of functional defects in RBD-specific B cell immunity in the elderly. One sentence summaryCirculating class-switched spike and RBD-specific memory B cells can outlast detectable neutralising antibodies but are functionally constrained in the elderly.
- organism: human
- assay: flow cytometry
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antibody and T cell memory immune response after two doses of the BNT162b2 mRNA vaccine in older adults with and without prior SARS-CoV-2 infection
J. Demaret, B. Corroyer-Simovic, … G. Lefevre·bioRxiv·Jul 8, 2021
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
R. Marzi, J. Bassi, … L. Piccoli·bioRxiv·Sep 30, 2022
- Robust and Functional Immunity up to 9 months after SARS-CoV-2 infection: a Southeast Asian longitudinal cohort
H. M. T. Vo, A. Maestri, … T. Cantaert·bioRxiv·Aug 12, 2021
- SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease
R. Reyes, K. Clarke, … E. M. Bunnik·bioRxiv·Sep 24, 2021
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response.
A. Sokal, P. Chappert, … M. Mahevas·bioRxiv·Nov 17, 2020